Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
biotech deals
Biotech
Altamira stakes for-sale sign again after asset deal crumbles
Altamira Therapeutics’ deal to sell subsidiary Zilentin and its inner ear R&D work has fallen through.
Gabrielle Masson
Jan 27, 2023 11:24am
GenKOre signs deals worth up to $650M for gene-editing tech
Jan 26, 2023 11:00am
Morphic loses another Big Pharma partner as J&J scraps pact
Jan 23, 2023 7:41am
JPM23, Day 3: Ionis CEO dampens PCSK9 hopes; Nektar forges on
Jan 11, 2023 6:08pm
JPM Day 2: BioNTech tackling symptomatic COVID, Editas' new plan
Jan 10, 2023 3:26pm
Karuna CEO says biotech can launch drugs too, amid deal rumors
Jan 10, 2023 1:21pm
